Development of a liquid chromatography/mass spectrometry assay for the bacterial transglycosylation reaction through measurement of Lipid II

Transglycosylation is the second to last step in the production of bacterial peptidoglycan. It is catalyzed by a transglycosylation site in class A penicillin‐binding proteins (PBPs) or monofunctional glycosyl transferases. Several potential inhibitors have been suggested and need to be tested for activity. In this article, we describe the development and validation of an LC/MS assay for Lipid II, the substrate for transglycosylation. The developed assay can be used to monitor the transglycosylation activity of Staphylococcus aureus PBP2. There was no need for modification of Lipid II with a fluorescent tag that could alter affinity of inhibitors toward Lipid II. Recombinant PBP2 was produced in Escherichia coli and has been tested for activity. This LC/MS method is suitable for a transglycosylation assay for PBP2 and since it is relatively fast, it can be used to test inhibitors.

[1]  G. D. de Jong,et al.  Comparison of capillary electrophoresis-mass spectrometry and hydrophilic interaction chromatography-mass spectrometry for anionic metabolic profiling of urine. , 2015, Talanta.

[2]  E. Adams,et al.  An overview of analytical methods for monitoring bacterial transglycosylation , 2014 .

[3]  V. R. Robledo,et al.  Review of the CE‐MS platform as a powerful alternative to conventional couplings in bio‐omics and target‐based applications , 2014, Electrophoresis.

[4]  M. Bassetti,et al.  Multidrug-resistant bacteria: what is the threat? , 2013, Hematology. American Society of Hematology. Education Program.

[5]  P. Nolan,et al.  Replication of Genome‐Wide association studies (GWAS) loci for sleep in the British G1219 cohort , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  S. Walker,et al.  Forming cross-linked peptidoglycan from synthetic gram-negative Lipid II. , 2013, Journal of the American Chemical Society.

[7]  D. Huhman,et al.  Mass Spectrometry Strategies in Metabolomics* , 2011, The Journal of Biological Chemistry.

[8]  Zengyou He,et al.  Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  U. Sauer,et al.  Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. , 2009, Analytical chemistry.

[10]  E. Sauvage,et al.  Importance of the Conserved Residues in the Peptidoglycan Glycosyltransferase Module of the Class A Penicillin-binding Protein 1b of Escherichia coli* , 2008, Journal of Biological Chemistry.

[11]  W. Vollmer,et al.  Murein (peptidoglycan) structure, architecture and biosynthesis in Escherichia coli. , 2008, Biochimica et biophysica acta.

[12]  B. de Kruijff,et al.  Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  Daniel Lim,et al.  Structural Insight into the Transglycosylation Step of Bacterial Cell-Wall Biosynthesis , 2007, Science.

[14]  M. Terrak,et al.  Kinetic Characterization of the Monofunctional Glycosyltransferase from Staphylococcus aureus , 2006, Journal of bacteriology.

[15]  Judy Halliday,et al.  Targeting the forgotten transglycosylases. , 2006, Biochemical pharmacology.

[16]  M. G. Pinho,et al.  Bacterial Cell Wall Synthesis: New Insights from Localization Studies , 2005, Microbiology and Molecular Biology Reviews.

[17]  P. Taylor.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. , 2005, Clinical biochemistry.

[18]  A. Heck,et al.  Lipid II Is an Intrinsic Component of the Pore Induced by Nisin in Bacterial Membranes* , 2003, Journal of Biological Chemistry.

[19]  B. Incledon,et al.  Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  A. Tomasz,et al.  Complementation of the Essential Peptidoglycan Transpeptidase Function of Penicillin-Binding Protein 2 (PBP2) by the Drug Resistance Protein PBP2A in Staphylococcus aureus , 2001, Journal of bacteriology.

[21]  D. Boger.  Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies † , 2001, Medicinal research reviews.

[22]  A. Tomasz,et al.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Pratt,et al.  Interactions of soluble penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus with moenomycin. , 1999, Biochemistry.

[24]  B. Berger-Bächi,et al.  The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Strominger,et al.  Biosynthesis of the peptidoglycan of bacterial cell walls. XII. Inhibition of cross-linking by penicillins and cephalosporins: studies in Staphylococcus aureus in vivo. , 1968, The Journal of biological chemistry.

[26]  D. Williams,et al.  The structure and mode of action of glycopeptide antibiotics of the vancomycin group. , 1984, Annual review of microbiology.

[27]  Q. Wang,et al.  Identification and Characterization of a Monofunctional Glycosyltransferase from Staphylococcus aureus , 2022 .